Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.27−0.04 (-0.35%)
Close on Nov 17, 2026Market cap $249.12MP/E –Yield –
Amarin pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Amarin's pe ratio was 134.5× on Apr 29, 2022.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Apr 29, 2022 | 134.5× | −342.5 |
| 2021 | Oct 29, 2021 | 477.0× | – |
See a number that looks wrong?